肺气肿对特发性肺纤维化肺功能生理及预后特征的影响
该研究在209例特发性肺纤维化(IPF)患者中,用基于纹理的自动定量系统在高分辨率CT上测量肺气肿范围,分析其对肺功能年下降率和预后的影响。结果显示肺气肿≥10%时,FVC年下降率和其预后意义均受影响,该范围或可用于定义CPFE。
要点
- IPF患者中肺气肿≥10%时,FVC年下降率及其预后意义均发生改变。
- 肺气肿≥10%和≥15%时,DLCO是最显著的预后因素。
- 肺气肿≥5%患者更多为男性和曾吸烟者,肺容积更保留且FVC下降率更低。
核心结论
- 在IPF中,肺气肿范围≥10%会影响FVC的年下降率及其预后意义,该范围可用于定义CPFE。
研究设计与样本
- 对209例IPF患者的高分辨率CT扫描进行基于纹理的自动定量系统测量肺气肿范围,分析其与肺功能年下降率及预后的关系。
主要发现
- 肺气肿范围≥5%者53例(25%),≥10%者23例(11%),≥15%者12例(6%)。
- 肺气肿≥5%患者更多为男性和曾吸烟者,肺容积更保留且FVC下降率更低。
- 无或轻微肺气肿患者中FVC下降率是死亡显著预测因子(HR 0.933,P<0.001),肺气肿≥5%患者中亦然(HR 0.906,P<0.001)。
- 肺气肿≥10%患者中DLCO是最显著预后因素(HR 0.972,P=0.040),≥15%患者中亦然(HR 0.942,P=0.023)。
- 肺气肿范围10% cut-off值在IPF患者FVC年下降率上产生最显著差异。
关键数值与推荐
- 肺气肿范围≥5%者53例(25%),≥10%者23例(11%),≥15%者12例(6%)。
- 无或轻微肺气肿患者FVC下降率预测死亡HR 0.933(P<0.001),肺气肿≥5%患者HR 0.906(P<0.001)。
- 肺气肿≥10%患者DLCO预测死亡HR 0.972(P=0.040),≥15%患者HR 0.942(P=0.023)。
- 肺气肿范围10% cut-off值在FVC年下降率上差异最显著。
临床怎么用
- 在IPF患者中评估肺气肿范围≥10%有助于识别CPFE,并影响对FVC下降率和DLCO预后价值的解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Combined pulmonary fibrosis and emphysema (CPFE) is characterized by preserved lung volume and slower lung function decline. However, it is unclear at what extent emphysema begins to impact respiratory physiology and prognostic characteristics in idiopathic pulmonary fibrosis (IPF). We estimated the extent of emphysema that could be used to define CPFE in IPF. METHODS: The extent of emphysema was observed on high-resolution computed tomography scans and measured by a texture-based automated quantification system in 209 IPF patients. We analysed the impact of differences in the extent of emphysema on the annual decline rate and prognostic significance of lung function parameters. RESULTS: The extent of emphysema was ≥5% in 53 patients (25%), ≥10% in 23 patients (11%) and ≥15% in 12 patients (6%). Patients with emphysema to an extent of ≥5% were more frequently men and ever-smokers; they had more preserved lung volume and lower forced vital capacity (FVC) decline rates than those with no or trivial emphysema. The FVC decline rate was a significant predictor of mortality in patients with no or trivial emphysema (hazard ratio (HR): 0.933, P < 0.001) and in patients with an extent of emphysema ≥5% (HR: 0.906, P < 0.001). However, diffusing capacity of the lung for carbon monoxide (DLCO ) was the most significant prognostic factor in those patients with an extent of emphysema ≥10% (HR: 0.972, P = 0.040) and ≥15% (HR: 0.942, P = 0.023). A 10% cut-off value for the extent of emphysema created the most significant difference in the annual FVC decline rate in IPF patients. CONCLUSION: In IPF, emphysema to an extent of ≥10% affects both the annual decline rate and the prognostic significance of FVC. This extent could be used to define CPFE.
引用
- Yoon HY, Kim TH, Seo JB, et al. Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis. Respirology. 2018. PMID: 30136753. doi:10.1111/resp.13387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。